$1000 Invested In This Stock 15 Years Ago Would Be Worth $14,000 Today

7/15/24 1:00:39 PM ET

Medical/Nursing Services

Health Care

Get the next $CHE alert in real time by email

Chemed (NYSE:CHE) has outperformed the market over the past 15 years by 6.44% on an annualized basis producing an average annual return of 18.98%. Currently, Chemed has a market capitalization of $8.11 billion.

Buying $1000 In CHE: If an investor had bought $1000 of CHE stock 15 years ago, it would be worth $13,515.05 today based on a price of $537.87 for CHE at the time of writing.

Chemed's Performance Over Last 15 Years

comp_fig

Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Get the next $CHE alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$CHE

Date	Price Target	Rating	Analyst
3/4/2022	$609.00 → $579.00	Outperform	RBC Capital
7/29/2021	$604.00 → $609.00	Outperform	RBC Capital

More analyst ratings

$CHE
Press Releases

Fastest customizable press release news feed in the world

Chemed Corporation Board of Directors Authorizes an Additional $300 Million for Stock Repurchase and Declares Quarterly Dividend of 50 Cents
Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has formally authorized an additional $300 million for stock repurchase under Chemed's existing share repurchase program. These share repurchases will be funded through a combination of cash generated from operations as well as utilization of its revolving credit facility. The Board of Directors has declared a quarterly cash dividend of 50-cents per share on the Company's capital stock, payable on December 6, 2024, to shareholders of record as of November 18, 2024. This is equal to the dividend paid in August 2024. This represents the 214th consecutive quarterly dividend paid by Chemed in its 53 years as a public com
11/8/24 11:43:00 AM ET
$CHE
Medical/Nursing Services
Health Care
Chemed Corporation to Present at the UBS 2024 Global Healthcare Conference
Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the UBS 2024 Global Healthcare Conference on Tuesday, November 12, 2024, at approximately 2:45 p.m. (ET) at the Terranea Resort in Rancho Palos Verdes, California. The presentation will be webcast live and can be accessed, along with the presentation materials, through the Chemed website at www.chemed.com (Investor Relations). The webcast replay will be available within 24 hours of the live presentation and will be accessible for 90 days. Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation (www.chemed.com) operates two wholly owned subsidiaries: VITAS Healthcare
11/5/24 12:00:00 PM ET
$CHE
Medical/Nursing Services
Health Care
Chemed Reports Third-Quarter 2024 Results
Chemed Corporation (Chemed) (NYSE:CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation's largest providers of end-of-life care, and Roto-Rooter, the nation's largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its third quarter ended September 30, 2024, versus the comparable prior-year period. Changes to Non-GAAP Metrics Chemed uses certain non-GAAP metrics such as EBITDA, adjusted EBITDA, adjusted net income and adjusted diluted earnings per share, to provide additional context and perspective to reported operational results. Chemed's previously reported non-GAAP metrics during the four sequential quart
10/29/24 4:15:00 PM ET
$CHE
Medical/Nursing Services
Health Care

Chemed Raises FY24 EPS From $23.30-$23.70 To $23.55-$23.80 Vs $23.21 Est.
Upward Revision to Guidance for 2024VITAS 2024 revenue, prior to Medicare Cap, is estimated to increase 16.3% to 17.3% when compared to 2023. ADC is estimated to increase 13.3% to 14.4%. Full year adjusted EBITDA margin, prior to Medicare Cap, is estimated to be 19.3% to 19.7%. We are currently estimating $8.5 million in Medicare Cap billing limitations in calendar 2024. The cost of the retention program negatively impacted VITAS' 2023 full year adjusted EBITDA by 159 basis points.Covenant Health is estimated to contribute approximately $30 million to $32 million of revenue to VITAS' full year revenue. There is no estimated Medicare Cap billing limitation expected related to Covenant Health.
7/24/24 4:19:21 PM ET
$CHE
Medical/Nursing Services
Health Care
Chemed Q2 Adj $5.47 Misses $5.59 Estimate, Sales $595.88M Miss $599.19M Estimate
Chemed (NYSE:CHE) reported quarterly earnings of $5.47 per share which missed the analyst consensus estimate of $5.59 by 2.15 percent. This is a 34.07 percent increase over earnings of $4.08 per share from the same period last year. The company reported quarterly sales of $595.88 million which missed the analyst consensus estimate of $599.19 million by 0.55 percent. This is a 7.60 percent increase over sales of $553.82 million the same period last year.
7/24/24 4:17:26 PM ET
$CHE
Medical/Nursing Services
Health Care
How Is The Market Feeling About Chemed?
Chemed's (NYSE:CHE) short percent of float has risen 11.16% since its last report. The company recently reported that it has 312 thousand shares sold short, which is 2.39% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.89 days to cover their short positions on average. Why Short Interest Matters Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises. Short interest is impo
7/16/24 2:45:17 PM ET
$CHE
Medical/Nursing Services
Health Care

$CHE
Financials

Live finance-specific insights

Chemed Corporation Board of Directors Authorizes an Additional $300 Million for Stock Repurchase and Declares Quarterly Dividend of 50 Cents
Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has formally authorized an additional $300 million for stock repurchase under Chemed's existing share repurchase program. These share repurchases will be funded through a combination of cash generated from operations as well as utilization of its revolving credit facility. The Board of Directors has declared a quarterly cash dividend of 50-cents per share on the Company's capital stock, payable on December 6, 2024, to shareholders of record as of November 18, 2024. This is equal to the dividend paid in August 2024. This represents the 214th consecutive quarterly dividend paid by Chemed in its 53 years as a public com
11/8/24 11:43:00 AM ET
$CHE
Medical/Nursing Services
Health Care
Chemed Reports Third-Quarter 2024 Results
Chemed Corporation (Chemed) (NYSE:CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation's largest providers of end-of-life care, and Roto-Rooter, the nation's largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its third quarter ended September 30, 2024, versus the comparable prior-year period. Changes to Non-GAAP Metrics Chemed uses certain non-GAAP metrics such as EBITDA, adjusted EBITDA, adjusted net income and adjusted diluted earnings per share, to provide additional context and perspective to reported operational results. Chemed's previously reported non-GAAP metrics during the four sequential quart
10/29/24 4:15:00 PM ET
$CHE
Medical/Nursing Services
Health Care
Chemed To Report Third-Quarter 2024 Earnings October 29, Related Conference Call To Be Held On October 30
Chemed Corporation (NYSE:CHE) today announced that it will release financial results for the third quarter ended September 30, 2024, on Tuesday, October 29, 2024, following the close of trading on the New York Stock Exchange. Chemed will host a conference call and webcast at 10 a.m., ET, on Wednesday, October 30, 2024, to discuss the company's quarterly results and to provide an update on its business. Participants may access a live webcast of the conference call through the investor relations section of Chemed's website, Investor Relations Home | Chemed Corporation or the hosting website https://edge.media-server.com/mmc/p/c93ntfig/. Participants may also register via teleconference at:
9/13/24 1:46:00 PM ET
$CHE
Medical/Nursing Services
Health Care

$CHE
Leadership Updates

Live Leadership Updates

VITAS To Buy Hospice Assets of Covenant Care in Florida and Alabama
VITAS Healthcare Corporation, a wholly-owned subsidiary of Chemed Corporation ("Chemed") (NYSE:CHE), announced it entered into an agreement on March 12, 2024 to acquire all hospice operations and an assisted living facility from Covenant Health and Community Services, Inc. d/b/a/ Covenant Care ("Covenant") for an aggregate purchase price of $85 million. Covenant's hospice operations span the panhandle of Florida and Alabama, specifically including the Tallahassee, Marianna, Fort Walton Beach, Panama City, Crestview and Pensacola markets in Florida, and the Dothan and Mobile/Daphne markets in Alabama. The transaction is structured as an asset purchase and parties will seek to close the tra
3/13/24 9:00:00 AM ET
$CHE
Medical/Nursing Services
Health Care
Chemed Corporation Announces the Appointment of Michael D. Witzeman as CFO
Chemed Corporation (NYSE:CHE) – Today Chemed Corporation's Board of Directors has appointed Michael D. Witzeman as Chief Financial Officer, effective January 1, 2024, following the retirement of David P. Williams from that role. Mr. Witzeman is currently Chemed's Vice President and Controller and serves as Chemed's principal accounting officer. He joined Chemed in 2005 following employment as Senior Manager of Assurance at Deloitte & Touche LLP. He is a licensed CPA and a BBA in Accounting from the University of Cincinnati and an MBA from The Ohio State University. Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation (www.chemed.com) operates t
12/18/23 1:20:00 PM ET
$CHE
Medical/Nursing Services
Health Care
Chemed Corporation Announces the Retirement of David P. Williams
Chemed Corporation (NYSE:CHE) – After more than three decades, Executive Vice President and Chief Financial Officer David P. Williams has announced that he will retire as Chemed's Chief Financial Officer as of December 31, 2023, but Mr. Williams will continue to work with Chemed for the transition period and beyond in providing his guidance and the benefit of his expertise to the executive team and the Board of Directors. Throughout his career, David helped lead Chemed and its subsidiaries through unprecedented economic growth. "It has been a privilege to work with David as an integral part of our management team for these last three decades," said Chemed Chief Executive Officer, Kevin
11/3/23 4:15:00 PM ET
$CHE
Medical/Nursing Services
Health Care

$1000 Invested In This Stock 15 Years Ago Would Be Worth $14,000 Today

Chemed's Performance Over Last 15 Years

Chat with this insight

Recent Analyst Ratings for $CHE

$CHE Press Releases

Fastest customizable press release news feed in the world

Chemed Corporation Board of Directors Authorizes an Additional $300 Million for Stock Repurchase and Declares Quarterly Dividend of 50 Cents

Chemed Corporation to Present at the UBS 2024 Global Healthcare Conference

Chemed Reports Third-Quarter 2024 Results

$CHE Large Ownership Changes

This live feed shows all institutional transactions in real time.

SEC Form SC 13G/A filed by Chemed Corp (Amendment)

SEC Form SC 13G/A filed by Chemed Corp (Amendment)

SEC Form SC 13G/A filed by Chemed Corp (Amendment)

$CHE SEC Filings

SEC Form 10-Q filed by Chemed Corp

Chemed Corp filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

SEC Form 10-Q filed by Chemed Corp

$CHE Market Insights

Live Market Insights

$CHE Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

$CHE Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

Chemed Raises FY24 EPS From $23.30-$23.70 To $23.55-$23.80 Vs $23.21 Est.

Chemed Q2 Adj $5.47 Misses $5.59 Estimate, Sales $595.88M Miss $599.19M Estimate

How Is The Market Feeling About Chemed?

SEC Form 4 filed by vice president Hutton Thomas C

SEC Form 4 filed by VP and Chief Legal Officer Judkins Brian C

SEC Form 4 filed by executive vice president Lee Spencer S

RBC Capital reiterated coverage on Chemed with a new price target

RBC Capital reiterated coverage on Chemed with a new price target

Oppenheimer reiterated coverage on Chemed with a new price target

$CHE Financials

Live finance-specific insights

Chemed Corporation Board of Directors Authorizes an Additional $300 Million for Stock Repurchase and Declares Quarterly Dividend of 50 Cents

Chemed Reports Third-Quarter 2024 Results

Chemed To Report Third-Quarter 2024 Earnings October 29, Related Conference Call To Be Held On October 30

$CHE Leadership Updates

Live Leadership Updates

VITAS To Buy Hospice Assets of Covenant Care in Florida and Alabama

Chemed Corporation Announces the Appointment of Michael D. Witzeman as CFO

Chemed Corporation Announces the Retirement of David P. Williams

Recent Analyst Ratings for
$CHE

$CHE
Press Releases

$CHE
Large Ownership Changes

$CHE
SEC Filings

$CHE
Market Insights

$CHE
Insider Trading

$CHE
Analyst Ratings

$CHE
Financials

$CHE
Leadership Updates